# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-066587
Filing Date
2024-05-30
Accepted
2024-05-30 16:10:03
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | 2024_-_proxy-_defa_14a.htm | DEFA14A | 21659
2 | GRAPHIC | img62829578_0.jpg | GRAPHIC | 833876
3 | GRAPHIC | img62829578_1.jpg | GRAPHIC | 387377
| Complete submission text file | 0000950170-24-066587.txt |  | 1701110

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 241005452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)